Molecular identification of extended-spectrum-β-lactamase genes from Enterobacteriaceae isolated from healthy human carriers in Switzerland

Antimicrob Agents Chemother. 2012 Mar;56(3):1609-12. doi: 10.1128/AAC.05539-11. Epub 2011 Dec 12.

Abstract

In this study, fecal samples from 586 healthy humans were investigated to determine the occurrence of extended-spectrum-β-lactamase (ESBL)-producing Enterobacteriaceae in Swiss people. A total of 5.8% of the human fecal samples yielded ESBL producers, and all of the 34 isolated strains were Escherichia coli. PCR analysis revealed that 14 strains produced CTX-M-15, 10 produced CTX-M-1, 7 strains produced CTX-M-14, and 2 strains produced CTX-M-2 ESBLs. One strain produced SHV-12 ESBL. Of the 34 isolates, 15 produced additional TEM-1 broad-spectrum β-lactamases. By serotyping, a high degree of diversity among the strains was found.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Carrier State
  • DNA, Bacterial / biosynthesis*
  • Escherichia coli / drug effects
  • Escherichia coli / genetics*
  • Escherichia coli / isolation & purification
  • Escherichia coli Infections / microbiology
  • Feces / microbiology
  • Female
  • Genetic Variation
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Plasmids
  • Polymerase Chain Reaction
  • Serotyping
  • Switzerland
  • beta-Lactamases / genetics*

Substances

  • DNA, Bacterial
  • beta-lactamase CTX-2
  • beta-lactamase SHV-12
  • beta-Lactamases
  • beta-lactamase TEM-1